Clinical Trials Browser

fasudil × Clear all

NCT06861192 2025-11-18

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Phase 2/3 Recruiting

Prostate CA

NCT06890858 2025-03-24

A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer

Phase 2 Recruiting

Ovarian Neoplasms